International Prostate Cancer Update Agenda 2019

Wednesday | January 23, 2019


3rd International Bladder Cancer Update

Michael S. Cookson, MD, MMHC (Co-Chair)

Daniel P. Petrylak, MD (Co-Chair)


IBCU/IPCU/LUGPA Welcome Reception – Upstairs Library

Thursday | January 24, 2019

7:00am-7:10 am IPCU Welcome and Opening Remarks
E. David Crawford, MD – Program Director
7:10am-7:20am The Present and Future of LUGPA
Richard G. Harris, MD, President, LUGPA


Moderator: A. Karim Kader, MD, PhD

7:20am – 7:30am PSA 1.5 Is the New 4.0
E. David Crawford, MD
7:30am – 7:40am How to Optimize the Use of Prostate-specific Antigen in the Current Era
Sigrid V. Carlsson, MD, PhD, MPH
7:40am – 7:50am Panel Discussion/Questions and Answers
7:50am – 8:30am Educational Breakfast Symposium
Biomarkers for Early- and Late-stage Prostate Cancer Patients
Speaker: David M. Albala, MD
Supported by Genomic Health
8:30am – 8:50am Panel on Pros and Cons of the AUA, NCCN, and EAU Screening Guidelines
Moderator: Michael S. Cookson, MD, MMHC
Panelists: Sigrid V. Carlsson, MD, PhD, MPH, Neal D. Shore, MD, and A. Karim Kader, MD, PhD
8:50am – 9:10am
Break and Visit Exhibits- Riverside Foyer
9:10am – 9:20am 2019 Economic Outlook for Urology in the United States
Deepak A. Kapoor MD
9:20am – 9:30am 29 MHz High Resolution Micro-Ultrasound: Improving Real-Time Targeting of Prostate Biopsies
Neal D. Shore, MD  
9:30am – 9:40am Using High Resolution Micro-Ultrasound for Prostate Biopsies
Laurence Klotz, MD
9:40am – 9:50am New Applications and Clinical Possibilities in Prostate Cancer with Micro-Ultrasound
E. David Crawford, MD
9:50am – 10:00am Discussion/Question and Answers
10:00am – 10:10am Urinary Micro RNAs and SNOs as a Prostate Cancer Biomarker Platform
Laurence Klotz, MD
10:10am – 10:20am

Live-Primary Cell Phenotypic Biomarkers and Prostate Cancer Prognosis

David M. Albala, MD

10:20am – 10:30am Panel Discussion/Question and Answers
10:30am – 10:40am Prostate Cancer Screening: The Latin American Perspective
Arturo Mendoza-Valdes, MD
10:40am-10:50am Prostate Cancer Active Surveillance in 2019
Sigrid V. Carlsson, MD, PhD, MPH
10:50am – 11:00am Panel Discussion/Question and Answers
11:00am Adjourn
11:00am – 3:30pm Poster Sessions – Open Viewing
Gondola Ballroom
3:30pm – 4:00pm Refreshments and Visit Exhibits – Riverside Foyer
4:00pm – 5:30pm


Moderator: Deepak A. Kapoor, MD

4:00pm – 4:30pm Panel Discussion on Integrating Cooperation Between LUGPA and Academic Medical Centers
Moderated by
Deepak A. Kapoor, MD
E. David Crawford, MD, Leonard G. Gomella, MD, Richard G. Harris, MD, Neal D. Shore, MD, R. Jonathan Henderson, MD, and Michael S. Cookson, MD MMHC
4:30pm – 4:40pm The AUA, CPT, and RUC: Interactions and Impact
Ronald P. Kaufman, Jr., MD, FACS
4:40pm –5:00pm Physician Burnout – What Can We Do To Prevent It?
Gerald L. Andriole, Jr., MD
5:00pm – 5:10pm Panel Discussion/Question and Answers
5:10pm – 5:30pm Panel Discussion on Women in Urology
Moderated by Wendy L. Poage, MHA
Panelists: Sigrid Carlsson, MD, PhD, MPH and Faina Shtern, MD
5:30pm – 5:45pm Break and Visit Exhibits – Riverside Foyer
5:45pm – 7:30pm


Moderator: Peter A. Pinto, MD

5:45pm – 5:55pm Brachytherapy/Caesium
Thomas J. Pugh, MD
5:55pm – 6:05pm 3DBiopsy™: Transperineal Mapping Biopsy
Nelson N. Stone, MD
6:05pm – 6:15pm Panel Discussion/Question and Answers
6:15pm – 6:25pm Salvage Lymph Node Dissection for Prostate Cancer
Paul D. Maroni, MD
6:25pm – 6:35pm TRUS Biopsy, MRI, and PROMIS Trial
Priya N. Werahera, PhD
6:35pm – 6:45pm Panel Discussion/Question and Answers
6:45pm – 6:55pm Second Opinion Diagnosis in Prostate Pathology
Francisco G. La Rosa, MD
6:55pm – 7:05pm Emerging Indications for a Novel Absorbable Hydrogel Spacer
Lawrence I. Karsh, MD, FACS
7:05pm – 7:15pm Focal Therapy for Localized Prostate Cancer: is There a “Middle Ground” Between Active Surveillance and Definitive Treatment?
John W. Davis, MD
7:15pm – 7:25pm Can MRI Be Used to Select Patients for Focal Therapy or To Guide Therapy?
Robert E. Reiter, MD
7:25pm – 7:35pm Panel Discussion/Question and Answers
7:35pm Adjourn and Evening On Own

Friday | January 25, 2019

7:00am – 9:00am


Moderator: Gerald L. Andriole, Jr., MD

7:00am – 7:10am mpMRI, PI-RADS, and Multi-Modality Image Fusion for Targeted Definition and Tissue Sampling
Jelle Barentsz, MD, PhD
7:10am – 7:20am Limitations of MRI
Peter A. Pinto, MD
7:20am – 7:30am Panel Discussion/Question and Answers
7:30am – 8:30am Educational Breakfast Symposium
Elevate Care in Advanced Prostate Cancer
Speaker: Neal D. Shore
Supported by Astellas Pharma US and Pfizer Oncology
8:30am – 8:40am Fluciclovine (18F) PET/CT Impact on Clinical Management of Recurrent Prostate Cancer
Gerald L. Andriole, Jr., MD
8:40am – 8:50am A Review of the Third Global Summit on Precision Diagnosis and Treatment of Prostate Cancer
Faina Shtern, MD
8:50am – 9:00am Panel Discussion/Question and Answers
9:00am – 9:20am Break and Visit Exhibits – Riverside Foyer
9:20am – 10:30am


Moderator: Richard G. Harris, MD

9:20am – 9:30am Tele-Health in Urology
Evan R. Goldfischer, MD, MBA
9:30am – 9:40am Future Options for Urology Practice Ownership
Gary M. Kirsh, MD
9:40am – 9:50am Panel Discussion/Question and Answers
9:50am – 10:00am What Makes Millennials Tick? Understanding the Young Urologist
Jason N. Hafron, MD
10:00am – 10:30am Panels on Careers in Academic Medicine vs. Careers in Independent and/or Group Practice
R. Jonathan Henderson, MD
Panel 1: Academic
Panelists: Gerald L. Andriole, Jr., MD, E. David Crawford, MD, Steven E. Finkelstein, MD, Leonard G. Gomella, MD, and Thomas E. Keane, MD
Panel 2: Independent Practice Panelists: Richard G. Harris, MD, Deepak A. Kapoor, MD, Gary M. Kirsh, MD, and Neal D. Shore, MD
10:30am Adjourn
10:45am – 12:45pm

Novel Technology Workshops on Micro-Ultrasound and Cryotherapy
Riverside Ballroom

3:30pm – 4:00pm Coffee Break and Visit Exhibits – Riverside Foyer
4:00pm – 5:30pm


Moderator: Mark A. Moyad, MD, MPH

4:00pm – 4:15pm The Men’s Eating and Living (MEAL) Study: Men Changed Diet But Not Prostate Cancer Progression
J. Kellogg Parsons, MD, MHS, FACS
4:15pm – 4:30pm B______, Statins, Aspirin, and Metformin (B.S.A.M.): The Best Natural Pill for Patients Concerned About Prostate Cancer
Mark A. Moyad, MD, MPH
4:30pm – 4:45pm Recovering Sexual Function After Prostate Cancer
Mohit Khera, MD, MBA, MPH
4:45pm – 4:55pm Panel Discussion/Question and Answers
4:55pm – 5:40pm Choosing the StrongPath™: Reversing the Downward Spiral of Aging
Fred H. Bartlit, Jr., JD
6:00pm – 7:00pm

Moderated Poster Sessions | Gondola Ballroom
Moderator: L. Michael Glode, MD

7:00pm- 7:30pm Cocktail Reception – Gondola Ballroom Foyer
7:30pm- 9:00pm 4th Annual Fred Bartlit, Jr. Dinner – Gondola Ballroom
Keynote Speaker: Congressman Neal Dunn, MD (R – Florida)

Saturday | January 26, 2019

7:45am – 8:30am Androgen Targeted Therapy Across the Continuum of  PCa
Scott B. Sellinger, MD
Supported by TOLMAR Pharmaceuticals
8:30am – 9:30am

Educational Breakfast Symposium

ERLEADA® (apalutamide) For the Treatment of Patients With Non-Metastatic Castration-Resistant Prostate Cancer
Speakers: Lawrence I. Karsh, MD, FACS and Steven E. Finkelstein, MD
Supported by Janssen Biotech

9:30am – 9:50am Break and Visit Exhibits – Riverside Foyer
9:50am – 11:00am


Moderator: Thomas E. Keane, MD

9:50am – 10:00am Timing of ADT with Chemotherapy
Thomas E. Keane, MD
10:00am – 10:20am

Point-Counterpoint: The Optimal Nadir T Level on ADT Is <20mg/mL

Pro:  E. David Crawford, MD
Con: John W. Davis, MD

10:20am – 10:30am Panel Discussion/Question and Answers
10:30am – 10:40am AR Resistance Mechanisms: Focusing on Variants and Testing
Raoul S. Concepcion, MD
10:40am – 10:50am New Considerations for Oligometastatic Prostate Cancer
Raoul S. Concepcion, MD
10:50am – 11:00am Panel Discussion/Question and Answers
11:00am Adjourn
3:30pm – 4:00pm Coffee Break and Visit Exhibits – Riverside Foyer
4:00pm – 5:45pm


Moderator: Daniel P. Petrylak, MD

4:00pm – 4:10pm Navigating the M0 Space – Results of RADAR III
Neal D. Shore, MD
4:10pm – 4:20pm Bone Metastases and Mortality: Can We Be Doing More?
Leonard G. Gomella, MD
4:20pm – 4:30pm Panel Discussion/Question and Answers
4:30pm – 4:40pm Immunotherapy for PCa: Where Do We Go From Here?
Daniel P. Petrylak, MD
4:40pm – 4:50pm PARP in Combination with Standard-of-care Treatment
Daniel P. Petrylak, MD
4:50pm – 5:00pm Panel Discussion/Question and Answers
5:00pm – 5:10pm Update on Clinical Trials of Radium-223
Phillip J. Koo, MD
5:10pm – 5:20pm Therapeutic Radiopharmaceuticals and the Emergence of Theranostics
Phillip J. Koo, MD
5:20pm – 5:30pm Panel Discussion/Question and Answers
5:30pm – 5:45pm Next Generation Learning: The Key Take Home Messages from IPCU 29
E. David Crawford, MD
5:45pm Adjourn